as on February 28, 2026 at 7:59 am IST
Day's Low
Day's High
3.16%
Downside
1.30%
Upside
52 Week's Low
52 Week's High
52.49%
Downside
27.99%
Upside
Check Beam Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.9B
EPS (TTM)
-4.2226
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-15.47
Industry PE ratio
8.434504504504504
PEG Ratio
0EBITDA
-361.4M
Revenue (TTM)
139.7M
Profit Margin
-57.24%
Return On Equity TTM
-8.11%
Track how Beam Therapeutics Inc P/E has moved over time to understand its valuation trends.
Beam Therapeutics Inc in the last 5 years
Lowest (-25.21x)
December 31, 2025
Today (-15.47x)
February 28, 2026
Industry (8.43x)
February 28, 2026
Highest (-3.87x)
June 30, 2025
Today’s Price to Earnings Ratio: -15.47x
Compare market cap, revenue, PE, and other key metrics of Beam Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.9B | NA | -15.47 | -57.24% | |
| BUY | $43.9B | 124.79% | 142.78 | 8.45% | |
| BUY | $122.0B | 133.75% | 31.34 | 32.94% | |
| NA | $35.7B | NA | 619.94 | 1.38% | |
| BUY | $81.5B | 73.48% | 18.59 | 31.41% |
The Beam Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Beam Therapeutics Inc investment value today
Current value as on today
₹1,12,263
Returns
₹12,263
(+12.26%)
Returns from Beam Therapeutics Inc Stock
₹8,087 (+8.09%)
Dollar Returns*
₹4,177 (+4.18%)
Based on 21 analysts
61.90%
Buy
38.10%
Hold
0.00%
Sell
Based on 21 analysts, 61.9% of analysts recommend a 'BUY' rating for Beam Therapeutics Inc. Average target price of $49.93
Get share price movements and forecasts by analysts on Beam Therapeutics Inc.
What analysts predicted
42.98%UPSIDE
Target Price
$49.93
Current Price
$28.47
Analyzed by
21 Analysts
Target
$49.93
Beam Therapeutics Inc target price $49.93, a slight upside of 42.98% compared to current price of $28.47. According to 21 analysts rating.
Investment in Beam Therapeutics Inc Shares on INDmoney has dropped by -17.52% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Beam Therapeutics Inc Stock has increased by 66% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:66% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -112.72M → 244.29M (in $), with an average increase of 146.1% per quarter
Revenue Rich
![]()
Revenue is up for the last 4 quarters, 7.47M → 114.10M (in $), with an average increase of 38.7% per quarter
Price Rise
![]()
In the last 6 months, BEAM stock has moved up by 68.9%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 73.9% return, outperforming this stock by 103.2%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 34.9% return, outperforming this stock by 26.9%
| Organisation | Beam Therapeutics Inc |
| Headquarters | 238 Main Street, Cambridge, MA, United States, 02142 |
| Industry | Health Technology |
| CEO | Mr. John M. Evans M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Christine P. Bellon J.D., Ph.D. | Senior VP, Chief Legal Officer & Corporate Secretary |
Dr. Feng Zhang Ph.D. | Co-Founder |
Dr. David R. Liu Ph.D. | Co-Founder |
Dr. J. Keith Joung M.D., Ph.D. | Co-Founder |
Dr. John Lo Ph.D. | Chief Commercial Officer |
Mr. John M. Evans M.B.A. | CEO & Director |
Mr. Sravan Kumar Emany | Chief Financial Officer |
Beam Therapeutics Inc share price today is $28.47 as on at the close of the market. Beam Therapeutics Inc share today touched a day high of $28.84 and a low of $27.57.
Beam Therapeutics Inc share touched a 52 week high of $36.44 on and a 52 week low of $13.53 on . Beam Therapeutics Inc stock price today i.e. is closed at $28.47,which is 21.87% down from its 52 week high and 110.50% up from its 52 week low.
Beam Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Beam Therapeutics Inc (BEAM) shares with as little as ₹90.988 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹909.88 in Beam Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Beam Therapeutics Inc share’s latest price of $28.47 as on February 28, 2026 at 2:29 am IST, you will get 0.3512 shares of Beam Therapeutics Inc. Learn more about
fractional shares .